News
Remegen Co. Ltd. emerged as a surprise challenger in the generalized myasthenia gravis space, unveiling positive phase III data of its China-approved lupus drug, telitacicept (RCT-18; Tai’ai), in the ...
If your daily moisturizer is made with comedogenic ingredients, they’re more likely to clog your pores and lead to pesky breakouts. “Certain moisturizers, particularly those containing heavier oils ...
The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in Systemic Lupus Erythematosus) study was officially completed on February 21, 2025 ...
Mononeuritis multiplex affects 1%–9% of people with systemic lupus erythematosus and requires urgent interspecialty involvement and treatment with immunosuppressive medications. A detailed history and ...
Saphnelo (anifrolumab-fnia) is a prescription drug used to treat systemic lupus erythematosus (SLE). It is given as an intravenous (IV) infusion by a healthcare professional. Saphnelo is used to ...
A rash on one or both eyelids is usually a sign of dermatitis. Many common environmental irritants, allergens, and daily activities can trigger the red, swollen, itchy skin of a dermatitis rash. Most ...
The Lupus Foundation of America is profoundly concerned by the reorganization and significant staff reductions taking place at the U.S. Department of Health and Human Services (HHS) in addition to ...
NGC 5530 is situated 40 million light-years away in the constellation Lupus (The Wolf). This galaxy is classified as a "flocculent" spiral, meaning that its spiral arms are patchy and indistinct.
Comedonal acne presents as many small papules, the same color as the surrounding skin, that make the skin appear bumpy. Types include whiteheads or closed comedones, blackheads, and open comedones ...
Patients with moderate to severe active systemic lupus erythematosus (SLE) who began treatment with anifrolumab in the TULIP-1 and TULIP-2 trials experienced a statistically significant reduction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results